Wesley E. Furnback
Floor 2, No. 17-1, Lane 113, Xiamen Street
TPQ, Taiwan
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Real-world treatment utilization patterns, discontinuation and healthcare resource utilization of first-line Bruton tyrosine kinase inhibitors among elderly patients ≥65 years in chronic lymphocytic leukemia.
Journal: Expert review of hematology
Published: February 10, 2026
Real-world treatment switching and sequencing to next line of therapy of zanubrutinib, acalabrutinib, and ibrutinib in chronic lymphocytic leukemia or small lymphocytic lymphoma.
Journal: Expert review of hematology
Published: February 09, 2026
Real-World Treatment Patterns and Healthcare Resource Utilization of Bruton Tyrosine Kinase Inhibitors for the Treatment of Mantle Cell Lymphoma in the United States.
Journal: Hematological oncology
Published: January 16, 2026
Real-world treatment patterns of Bruton tyrosine kinase inhibitors in mantle cell lymphoma in a community oncology setting.
Journal: Future oncology (London, England)
Published: September 08, 2025
The financial value of improving patient access to COVID-19 antiviral therapy in Medicare Part D: A simulation study.
Journal: Journal of managed care & specialty pharmacy
Published: May 05, 2025
A Systematic Literature Review of the Economic and Healthcare Resource Utilization Burden of Relapsed/Refractory Follicular Lymphoma.
Journal: PharmacoEconomics - open
Published: March 25, 2025
Estimating the Cost-Effectiveness of Tumor Treating Fields (TTFields) Therapy with an Immune Checkpoint Inhibitor or Docetaxel in Metastatic Non-Small Cell Lung Cancer.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: October 17, 2024
Clinical Trial and Real-World Outcomes of Patients With Metastatic NSCLC in the Post-Platinum-Based Chemotherapy Failure Setting.
Journal: JTO clinical and research reports
Published: April 27, 2023
The Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine in Seven Chinese Cities.
Journal: Vaccines
Published: October 11, 2021
Health-Related Quality of Life for Patients Receiving Tumor Treating Fields for Glioblastoma.
Journal: Frontiers in oncology
Published: September 07, 2021
A systematic literature review of economic evaluations of pneumococcal conjugate vaccines in east and southeast Asia (2006-2019).
Journal: Expert review of vaccines
Published: March 08, 2021
Relationship between transfusion burden, healthcare resource utilization, and complications in patients with beta-thalassemia in Taiwan: A real-world analysis.
Journal: Transfusion
Published: January 15, 2021
Last Updated: 09/26/2026